NHS overturns psychologist’s sterilisation denial amid persistent gender‑based procedural disparity

After a prolonged attempt to obtain a tubal ligation through the National Health Service, psychologist Leah Spasova was denied the procedure only to have the decision subsequently reversed following an intervention by the health ombudsman, a development that brings the longstanding asymmetry between female sterilisation and male vasectomy access back into sharp focus. The case, which culminated in May 2026, consequently spotlights the procedural safeguards and eligibility thresholds that have, according to critics, been applied with a markedly different stringency to women seeking permanent contraception compared with their male counterparts.

Spasova, who had pursued the operation for several years, faced repeated refusals on grounds ranging from alleged medical unsuitability to budgetary constraints, a pattern that mirrors the broader tendency of NHS trusts to impose more restrictive criteria on female sterilisation than on comparable male procedures, thereby engendering a de facto disparity in reproductive autonomy. When the appeal reached the health ombudsman, the investigatory body concluded that the denial lacked sufficient justification under existing clinical guidelines, ordering the NHS to reassess the case and ultimately to authorize the tubal ligation, a decision that, while remedial for the individual, underscores the systemic opacity that has permitted such differential treatment to persist.

The juxtaposition of this outcome with the relatively uncontroversial access men enjoy to vasectomy services reveals a policy incongruity in which the same health system that professes equity in principle continues to endorse procedural gatekeeping that disproportionately burdens women, thereby reinforcing a paternalistic paradigm that privileges cost‑containment over genuine informed choice. Consequently, the episode serves as a reminder that without a comprehensive review of the eligibility frameworks governing permanent contraception, and without transparent accountability mechanisms to monitor gender‑based discrepancies, the NHS is likely to repeat such avoidable denials, perpetuating a cycle in which the rhetoric of patient autonomy remains largely rhetorical.

Published: May 1, 2026

Published: May 1, 2026